Excellagen Case Study – Dr. Arthur Tallis, Phoenix, AZ | New Treatment for Venous Ulcers | Diabetes and Foot Care

NEWS | CONTACT US

Venous Leg Ulcer Case Study. Arthur Tallis, DPM, FACFAS, Phoenix, AZ

Day 1: Pretreatment

Day 56: After Four Applications
of Excellagen (Unna Boot Worn from Day 27 to 56)

Excellagen applied biweekly, following debridement.

Patient Data
Age	62
Sex	Male
General Health Status	Venous Insufficiency
Wound Duration Prior to Treatment	13 Months
Prior Treatment	Anticoagulants, Four-layer compression dressing

Excellagen is indicated for the management of wounds. Although many patients benefit from the use of the product, results may vary. Please see full prescribing information.

Download
Case Study

Excellagen is indicated for the management of wounds including partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/ undermined wounds, surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, and skin tears) and draining wounds. Excellagen is contraindicated for individuals with a known sensitivity to products of bovine origin.

Excellagen is for use by healthcare professionals in the United States. All information, including the prescribing information for Excellagen, follows laws, regulatory requirements, and medical practices for the United States only and may not be appropriate for use outside of the United States. Detailed information about Excellagen can be found in the Package Insert and the Directions for Use.